Oramed Pharma
(ORMP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 08-2016 | |
| Sales | 2,710 | 2,703 | 2,449 | 2,456 | 641 |
| Cost of Goods | N/A | 90 | -86 | 187 | 490 |
| Gross Profit | 2,710 | 2,613 | 2,535 | 2,269 | 151 |
| Operating Expenses | 14,467 | 17,334 | 15,976 | 13,227 | 10,651 |
| Operating Income | -11,757 | -14,631 | -13,527 | -10,771 | -10,010 |
| Interest Expense | 444 | 485 | 103 | 101 | 93 |
| Other Income | 690 | 1,061 | 903 | 792 | 474 |
| Pre-tax Income | -11,511 | -14,055 | -12,727 | -10,080 | -9,629 |
| Income Tax | N/A | 300 | N/A | 400 | 1,335 |
| Net Income Continuous | -11,511 | -14,355 | -12,727 | -10,480 | -10,964 |
| Net Income | $-11,511 | $-14,355 | $-12,727 | $-10,480 | $-10,964 |
| EPS Basic Total Ops | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 |
| EPS Basic Continuous Ops | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 |
| EPS Diluted Total Ops | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 |
| EPS Diluted Continuous Ops | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 |
| EBITDA(a) | $-11,750 | $-14,623 | $-13,521 | $-10,766 | $-10,006 |